Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Q2 2026 revenue rose 48% to a record $28.3 million, with record net income and adjusted EBITDA plus raised full-year guidance; shares gained 44.6% through August 26, supporting near-term continuation potential.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Margin Expansion ⢠Weak Cash Flow ⢠Liquidity Pressure PAYS shows improving profitability and low debt, but weak cash conversion, tight working capital, and elevated valuation warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Recent rebound ⢠Below average ⢠Resistance overhead Support Level: $11.82â$12.00 Resistance Level: $12.80â$13.00 PAYS remains cautiously bearish last month, rebounding from $11.82 but needing to reclaim $12.80â$13.00 while holding $11.82â$12.00 support.
Sentiment & News
Key News Insights: ⢠Zacks upgrade ⢠Revenue target ⢠BlackRock stake Paysign's upgraded outlook, $117M revenue target, and BlackRock stake signal strengthening growth momentum.
AI Summary
PAYS is evolving into a higher-margin life-sciences payments platform, but after its sharp rerating, investors should only add exposure if patient-affordability growth and elevated margins translate into sustained free cash flow rather than working-capital-driven earnings.
Description
Paysign, Inc. provides prepaid card programs, patient affordability services, digital banking tools, and payment processing services for businesses, consumers, and government entities. Its offerings support use cases such as rewards, rebates, incentive payments, healthcare reimbursement, and pharmaceutical assistance, along with cardholder support and digital account access. The company was founded in 2001 and is based in Henderson, Nevada.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Aug 26 | Sep 2 | PAYS | Paysign, Inc. | Q2 2026 revenue rose 48% to a record $28.3 million, with record net income and adjusted EBITDA plus raised full-year guidance; shares gained 44.6% through August 26, supporting near-term continuation potential. | Closed | -5.3% |